1
|
Rovani S, Rahshenas M, Salomon LJ, Benachi A, Choupeaux L, Goua V, Jouannic JM, Bouar GL, Massardier J, Rosenblatt J, Sartor A, Thong-Vanh C, Vaast P, Lelong N, Khoshnood B, Delacourt C. Impact of prenatal estimation of the risk of respiratory distress in neonates with congenital pulmonary malformations on the choice of delivery site. Arch Pediatr 2023; 30:195-200. [PMID: 37061356 DOI: 10.1016/j.arcped.2023.03.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2022] [Revised: 11/07/2022] [Accepted: 03/04/2023] [Indexed: 04/17/2023]
Abstract
BACKGROUND The vast majority of prenatally diagnosed congenital pulmonary malformations (CPM) remain asymptomatic at birth. The maximal value of the CPM volume ratio (CVRmax) predicts the risk of neonatal respiratory distress (NRD), and should allow for better assessment of the level of expertise needed at the delivery site. AIM This study evaluated the level of maternity units currently chosen for the delivery of CPMs, and determined the impact of the choice of delivery site based on the CVRmax, with a threshold of 0.4 cm2. METHODS Data were extracted from the French prospective MALFPULM cohort, with inclusion between March 2015 and June 2018. RESULTS The final study population consisted of 383 women. Deliveries in level 1 or 2 maternity units (n = 98, 25%) involved CPMs with lower CVRmax (p<0.001), causing fewer signs of prenatal compression (p = 0.025). Among the 62 children (16%) who presented with NRD, only seven (11%) were born in level 1 or 2 units (p = 0.0078). Choosing the maternity level according to the CVRmax would have increased the number of births in level 1 or 2 maternity hospitals by 70%. In these maternity units, the percentage of children with NRD would have increased from 8% in the actual distribution to 10% in the new strategy. CONCLUSION Our results showed an overuse of level 3 maternity hospitals for the delivery of newborns with a prenatal diagnosis of CPM. The use of CVRmax should enable a reduction in the use of expertise centers without an adverse impact on newborns.
Collapse
Affiliation(s)
- S Rovani
- AP-HP, Hôpital Necker-Enfants Malades, Service de Pneumologie et Allergologie Pédiatriques, Paris, France
| | - M Rahshenas
- Inserm UMR 1153, Maternité Port-Royal, Paris, France
| | - L J Salomon
- Université de Paris Cité, Paris, France; AP-HP, Hôpital Necker-Enfants Malades, Service d'Obstétrique, Paris, France
| | - A Benachi
- AP-HP, Hôpital Antoine Béclère, Service de Gynécologie-Obstétrique, Université Paris Sud, Clamart, France
| | - L Choupeaux
- AP-HP, Unité de recherche clinique Cochin-Necker, Paris, France
| | - V Goua
- Service d'Obstétrique, CHU Poitiers, France
| | - J-M Jouannic
- AP-HP, Hôpital Armand-Trousseau, Service de Gynécologie-Obstétrique, Université Paris Sorbonne, France
| | - G Le Bouar
- Service d'Obstétrique, CHU Rennes, France
| | - J Massardier
- Hospices Civils de Lyon, HFME, Service d'Obstétrique, France
| | - J Rosenblatt
- AP-HP, Hôpital Robert Debré, Service d'Obstétrique, Paris, France
| | - A Sartor
- Service d'Obstétrique, CHU Toulouse, France
| | | | - P Vaast
- Service d'Obstétrique, CRHU Lille, France
| | - N Lelong
- Inserm UMR 1153, Maternité Port-Royal, Paris, France
| | - B Khoshnood
- Inserm UMR 1153, Maternité Port-Royal, Paris, France
| | - C Delacourt
- AP-HP, Hôpital Necker-Enfants Malades, Service de Pneumologie et Allergologie Pédiatriques, Paris, France; Université de Paris Cité, Paris, France.
| |
Collapse
|
2
|
van Bodegom LS, Gerritsen SE, Dieleman GC, Overbeek MM, de Girolamo G, Scocco P, Hillegers MHJ, Wolke D, Rizopoulos D, Appleton R, Conti P, Franić T, Margari F, Madan J, McNicholas F, Nacinovich R, Pastore A, Paul M, Purper-Ouakil D, Saam MC, Santosh PJ, Sartor A, Schulze UME, Signorini G, Singh SP, Street C, Tah P, Tanase E, Tremmery S, Tuomainen H, Maras A. The importance of clinicians' and parents' awareness of suicidal behaviour in adolescents reaching the upper age limit of their mental health services in Europe. J Affect Disord 2023; 325:360-368. [PMID: 36621680 DOI: 10.1016/j.jad.2022.12.164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/19/2022] [Revised: 12/29/2022] [Accepted: 12/31/2022] [Indexed: 01/07/2023]
Abstract
BACKGROUND To study clinicians' and parents' awareness of suicidal behaviour in adolescents reaching the upper age limit of their Child and Adolescent Mental Health Service (CAMHS) and its association with mental health indicators, transition recommendations and mental health service (MHS) use. METHODS 763 CAMHS users from eight European countries were assessed using multi-informant and standardised assessment tools at baseline and nine months follow-up. Separate ANCOVA's and pairwise comparisons were conducted to assess whether clinicians' and parents' awareness of young people's suicidal behaviour were associated with mental health indicators, clinician's recommendations to continue treatment and MHS use at nine months follow-up. RESULTS 53.5 % of clinicians and 56.9 % of parents were unaware of young people's self-reported suicidal behaviour at baseline. Compared to those whose clinicians/parents were aware, unawareness was associated with a 72-80 % lower proportion of being recommended to continue treatment. Self-reported mental health problems at baseline were comparable for young people whose clinicians and parents were aware and unaware of suicidal behaviour. Clinicians' and parents' unawareness were not associated with MHS use at follow-up. LIMITATIONS Aspects of suicidal behaviour, such as suicide ideation, -plans and -attempts, could not be distinguished. Few young people transitioned to Adult Mental Health Services (AMHS), therefore power to study factors associated with AMHS use was limited. CONCLUSION Clinicians and parents are often unaware of suicidal behaviour, which decreases the likelihood of a recommendation to continue treatment, but does not seem to affect young people's MHS use or their mental health problems.
Collapse
Affiliation(s)
- Larissa S van Bodegom
- Yulius Mental Health Organization, Yulius Academy, Dordrecht 3300 BA, Netherlands; Erasmus Medical Center, Department of Child and Adolescent Psychiatry and Psychology, Rotterdam 3000 CB, Netherlands
| | - Suzanne E Gerritsen
- Erasmus Medical Center, Department of Child and Adolescent Psychiatry and Psychology, Rotterdam 3000 CB, Netherlands
| | - Gwendolyn C Dieleman
- Erasmus Medical Center, Department of Child and Adolescent Psychiatry and Psychology, Rotterdam 3000 CB, Netherlands.
| | - Mathilde M Overbeek
- Yulius Mental Health Organization, Yulius Academy, Dordrecht 3300 BA, Netherlands; Vrije Universiteit Amsterdam, Clinical Child and Family Studies, Amsterdam, 1081 BT, Netherlands
| | - Giovanni de Girolamo
- IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Psychiatric Epidemiology and Evaluation Unit, Brescia 25125, Italy
| | - Paolo Scocco
- ULSS 6 Euganea, Department of Mental health, Padova 35131, Italy
| | - Manon H J Hillegers
- Erasmus Medical Center, Department of Child and Adolescent Psychiatry and Psychology, Rotterdam 3000 CB, Netherlands
| | - Dieter Wolke
- University of Warwick, Department of Psychology, Coventry CV4 7AL, United Kingdom
| | - Dimitris Rizopoulos
- Erasmus Medical Center, Department of Biostatistics, Rotterdam 3000 CB, Netherlands; Erasmus Medical Center, Department of Epidemiology, Rotterdam 3000 CB, Netherlands
| | - Rebecca Appleton
- University College London, NIHR Mental Health Policy Research Unit, Division of Psychiatry, London W1T 7NF, United Kingdom
| | - Patrizia Conti
- ASST Lariana, Department of Child and Adolescent Psychiatry, Como 22100, Italy
| | - Tomislav Franić
- University Hospital Split, Department of Psychiatry, Split 21000, Croatia; University of Split, School of Medicine, Split 21000, Croatia
| | | | - Jason Madan
- University of Warwick, Warwick Medical School, Coventry CV4 7AL, United Kingdom
| | - Fiona McNicholas
- University College Dublin, School of Medicine & Medical Science, Dublin D04 V1W8, Republic of Ireland, United Kingdom; SJOG, Lucena CAMHS, Dublin, Republic of Ireland, United Kingdom
| | - Renata Nacinovich
- University of Milan Bicocca, Child and Adolescent Neuropsychiatry Unit S. Gerardo Hospital, Monza 20052, Italy
| | - Adriana Pastore
- University of Bari, Unit of Adolescent Psychiatric Emergency, Bari 70121, Italy
| | - Moli Paul
- University of Warwick, Warwick Medical School, Coventry CV4 7AL, United Kingdom
| | - Diane Purper-Ouakil
- Saint Eloi Hospital, Centre Hospitalier Universitaire de Montpellier, Montpellier 34090, France; INSERM, CESP U1018, PsyDev, University Paris Saclay, UVSQ, Versailles, France
| | - Melanie C Saam
- University of Ulm, Department of Child and Adolescent Psychiatry/Psychotherapy, Ulm 89075, Germany
| | - Paramala J Santosh
- Kings College London, Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, London SE5 8AF, United Kingdom; South London and Maudsley NHS Foundation Trust, Centre for Interventional Paediatric Psychopharmacology and Rare Diseases, London SE5 8AZ, United Kingdom; HealthTracker Ltd, Kent ME7 1AY, United Kingdom
| | - Anne Sartor
- Josefinum Augsburg, Klinik für Kinder- und Jugendpsychiatrie und Psychotherapie, Augsburg 86154, Germany
| | - Ulrike M E Schulze
- University of Ulm, Department of Child and Adolescent Psychiatry/Psychotherapy, Ulm 89075, Germany
| | - Giulia Signorini
- IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Psychiatric Epidemiology and Evaluation Unit, Brescia 25125, Italy
| | - Swaran P Singh
- University of Warwick, Warwick Medical School, Coventry CV4 7AL, United Kingdom
| | - Cathy Street
- University of Warwick, Warwick Medical School, Coventry CV4 7AL, United Kingdom
| | - Priya Tah
- University of Warwick, Warwick Medical School, Coventry CV4 7AL, United Kingdom; Rees Centre, Department of Education, University of Oxford, Oxford OX2 6PY, United Kingdom
| | - Elena Tanase
- University of Ulm, Department of Child and Adolescent Psychiatry/Psychotherapy, Ulm 89075, Germany
| | - Sabine Tremmery
- KU Leuven, Department of Neurosciences, Leuven BE-3000, Belgium
| | - Helena Tuomainen
- University of Warwick, Warwick Medical School, Coventry CV4 7AL, United Kingdom
| | - Athanasios Maras
- Yulius Mental Health Organization, Yulius Academy, Dordrecht 3300 BA, Netherlands
| | | |
Collapse
|
3
|
Dubucs C, Groussolles M, Ousselin J, Sartor A, Van Acker N, Vayssière C, Pasquier C, Reyre J, Batlle L, Favarel S, Duchanois D, Jauffret V, Courtade-Saïdi M, Aziza J. Lésions placentaires graves dues à une infection maternelle par le SARS-CoV-2 associées à une mort fœtale intra-utérine. Morphologie 2022. [PMCID: PMC9376011 DOI: 10.1016/j.morpho.2022.06.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
L’infection par le SRAS-CoV-2 peut provoquer des lésions placentaires sévères conduisant rapidement à une mort fœtale intra-utérine (MFIU). Entre août 2020 et septembre 2021, nous avons reçu et analysé 50 placentas de mères non vaccinées positives au COVID-19, dans le service de pathologie de Toulouse. Le but de notre étude est de décrire les caractéristiques clinicopathologiques de ces atteintes placentaires et d’en comprendre la physiopathologie. Dix d’entre eux (20 %) présentaient des lésions placentaires avec une immunohistochimie positive au SARS-CoV-2 au niveau du trophoblaste villositaire. Dans cinq cas (10 %), nous avons observé des lésions placentaires massives associant nécrose trophoblastique, dépôts fibrinoides, intervillite ainsi que des modifications hémorragiques étendues dues à l’infection par le SARS-CoV-2 probablement responsable de la MFIU par insuffisance placentaire fonctionnelle. Dans cinq autres cas, nous avons trouvé des lésions placentaires similaires mais avec une distribution focale ayant conduit à une naissance vivante. Ces lésions sont indépendantes de la sévérité clinique maternelle de l’infection à COVID-19 car elles surviennent malgré des symptômes maternels bénins les rendant difficiles à prévoir. Dans nos cas, elles sont apparues 1 à 3 semaines après un test RT-PCR maternel positif au SRAS-CoV-2 et ont été observées au cours des 2e et 3e trimestres de la grossesse. Lorsque ces lésions sont focales, elles n’entraînent pas de MFIU mais peuvent être associées à un retard de croissance intra-utérin.
Collapse
|
4
|
Gerritsen SE, van Bodegom LS, Dieleman GC, Overbeek MM, Verhulst FC, Wolke D, Rizopoulos D, Appleton R, van Amelsvoort TAMJ, Bodier Rethore C, Bonnet-Brilhault F, Charvin I, Da Fonseca D, Davidović N, Dodig-Ćurković K, Ferrari A, Fiori F, Franić T, Gatherer C, de Girolamo G, Heaney N, Hendrickx G, Jardri R, Kolozsvari A, Lida-Pulik H, Lievesley K, Madan J, Mastroianni M, Maurice V, McNicholas F, Nacinovich R, Parenti A, Paul M, Purper-Ouakil D, Rivolta L, de Roeck V, Russet F, Saam MC, Sagar-Ouriaghli I, Santosh PJ, Sartor A, Schulze UME, Scocco P, Signorini G, Singh SP, Singh J, Speranza M, Stagi P, Stagni P, Street C, Tah P, Tanase E, Tremmery S, Tuffrey A, Tuomainen H, Walker L, Wilson A, Maras A. Demographic, clinical, and service-use characteristics related to the clinician's recommendation to transition from child to adult mental health services. Soc Psychiatry Psychiatr Epidemiol 2022; 57:973-991. [PMID: 35146551 PMCID: PMC9042957 DOI: 10.1007/s00127-022-02238-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/07/2021] [Accepted: 01/22/2022] [Indexed: 11/26/2022]
Abstract
PURPOSE The service configuration with distinct child and adolescent mental health services (CAMHS) and adult mental health services (AMHS) may be a barrier to continuity of care. Because of a lack of transition policy, CAMHS clinicians have to decide whether and when a young person should transition to AMHS. This study describes which characteristics are associated with the clinicians' advice to continue treatment at AMHS. METHODS Demographic, family, clinical, treatment, and service-use characteristics of the MILESTONE cohort of 763 young people from 39 CAMHS in Europe were assessed using multi-informant and standardized assessment tools. Logistic mixed models were fitted to assess the relationship between these characteristics and clinicians' transition recommendations. RESULTS Young people with higher clinician-rated severity of psychopathology scores, with self- and parent-reported need for ongoing treatment, with lower everyday functional skills and without self-reported psychotic experiences were more likely to be recommended to continue treatment. Among those who had been recommended to continue treatment, young people who used psychotropic medication, who had been in CAMHS for more than a year, and for whom appropriate AMHS were available were more likely to be recommended to continue treatment at AMHS. Young people whose parents indicated a need for ongoing treatment were more likely to be recommended to stay in CAMHS. CONCLUSION Although the decision regarding continuity of treatment was mostly determined by a small set of clinical characteristics, the recommendation to continue treatment at AMHS was mostly affected by service-use related characteristics, such as the availability of appropriate services.
Collapse
Affiliation(s)
- S E Gerritsen
- Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, P.O. Box 2060, 3000 CB, Rotterdam, The Netherlands
| | - L S van Bodegom
- Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, P.O. Box 2060, 3000 CB, Rotterdam, The Netherlands
- Yulius Academy, Yulius Mental Health Organization, Dordrecht, The Netherlands
| | - G C Dieleman
- Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, P.O. Box 2060, 3000 CB, Rotterdam, The Netherlands.
| | - M M Overbeek
- Yulius Academy, Yulius Mental Health Organization, Dordrecht, The Netherlands
- Clinical Child and Family Studies, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - F C Verhulst
- Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, P.O. Box 2060, 3000 CB, Rotterdam, The Netherlands
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
| | - D Wolke
- Department of Psychology, University of Warwick, Coventry, UK
| | - D Rizopoulos
- Department of Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands
| | - R Appleton
- NIHR Mental Health Policy Research Unit, Division of Psychiatry, University College London, London, UK
| | - T A M J van Amelsvoort
- Department of Psychiatry and Neuropsychology, University of Maastricht, Maastricht, The Netherlands
- Mondriaan Mental Health Care, Heerlen, The Netherlands
| | | | | | - I Charvin
- Centre Hospitalier Universitaire de Marseille, Marseille, France
| | - D Da Fonseca
- Centre Hospitalier Universitaire de Marseille, Marseille, France
| | - N Davidović
- University Hospital Split, Split, Croatia
- School of Medicine, University of Split, Split, Croatia
| | - K Dodig-Ćurković
- Faculty for Dental Care and Health, Osijek, Croatia
- University Health Center Osijek, Osijek, Croatia
- Unit for Child and Adolescent Psychiatry, Osijek, Croatia
| | - A Ferrari
- IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
- DISM, ULSS 16, SOPROXI Onlus, Padua, Italy
| | - F Fiori
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK
- Centre for Interventional Paediatric Psychopharmacology and Rare Diseases, South London and Maudsley NHS Foundation Trust, London, UK
- HealthTracker Ltd, Kent, UK
| | - T Franić
- University Hospital Split, Split, Croatia
- School of Medicine, University of Split, Split, Croatia
| | - C Gatherer
- Warwick Medical School, University of Warwick, Coventry, UK
| | - G de Girolamo
- IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - N Heaney
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK
| | - G Hendrickx
- Department of Neurosciences, Centre for Clinical Psychiatry, KU Leuven, Leuven, Belgium
| | - R Jardri
- Lille Neurosciences and Cognitions, Plasticity and Subjectivity Team, CURE Platform, Université de Lille, INSERM (U-1172), Fontan Hospital, CHU Lille, Lille, France
| | | | | | - K Lievesley
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK
| | - J Madan
- Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK
| | - M Mastroianni
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK
- Centre for Interventional Paediatric Psychopharmacology and Rare Diseases, South London and Maudsley NHS Foundation Trust, London, UK
| | - V Maurice
- Centre Hospitalier Universitaire de Montpellier, Saint Eloi Hospital, Montpellier, France
| | - F McNicholas
- School of Medicine & Medical Science, University College Dublin, Dublin, Republic of Ireland
- Lucena CAMHS, SJOG, Dublin, Republic of Ireland
| | - R Nacinovich
- Child and Adolescent Neuropsychiatry Unit, ASST Monza, Monza, Italy
- Università Degli Studi Milano Bicocca, Milan, Italy
| | - A Parenti
- Centre Hospitalier Universitaire de Lille, Lille, France
| | - M Paul
- Warwick Medical School, University of Warwick, Coventry, UK
- Coventry and Warwickshire Partnership NHS Trust, Coventry, UK
| | - D Purper-Ouakil
- Centre Hospitalier Universitaire de Montpellier, Saint Eloi Hospital, Montpellier, France
- INSERM, CESP U1018, PsyDev, University Paris Saclay, UVSQ, Versailles, France
| | - L Rivolta
- Psychiatric Epidemiology and Evaluation Unit, Saint John of God Clinical Research Center, Brescia, Italy
- Department of Mental Health, Psychiatry Unit, San Gerardo Hospital, Monza, Monza Brianza, Italy
| | - V de Roeck
- Department of Neurosciences, KU Leuven, Leuven, Belgium
- Child and Youth Studies, Campus Social School, University Colleges Leuven Limburg, Heverlee, Belgium
| | - F Russet
- Centre Hospitalier Universitaire de Montpellier, Saint Eloi Hospital, Montpellier, France
| | - M C Saam
- Department of Child and Adolescent Psychiatry/Psychotherapy, University of Ulm, Ulm, Germany
| | - I Sagar-Ouriaghli
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK
| | - P J Santosh
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK
- Centre for Interventional Paediatric Psychopharmacology and Rare Diseases, South London and Maudsley NHS Foundation Trust, London, UK
- HealthTracker Ltd, Kent, UK
| | - A Sartor
- Josefinum Augsburg, Klinik für Kinder- und Jugenspsychiatrie und Psychotherapie, Augsburg, Germany
| | - U M E Schulze
- Department of Child and Adolescent Psychiatry/Psychotherapy, University of Ulm, Ulm, Germany
| | - P Scocco
- Department of Mental Health, ULSS 6 Euganea, Padua, Italy
- SOPROXI Onlus, Padua, Italy
| | - G Signorini
- IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - S P Singh
- Warwick Medical School, University of Warwick, Coventry, UK
| | - J Singh
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK
- Centre for Interventional Paediatric Psychopharmacology and Rare Diseases, South London and Maudsley NHS Foundation Trust, London, UK
| | - M Speranza
- INSERM, CESP U1018, PsyDev, University Paris Saclay, UVSQ, Versailles, France
- Service Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Centre Hospitalier de Versailles, Versailles, France
| | - P Stagi
- Child and Adolescent Neuropsychiatry Unit, AUSL Modena, Modena, Italy
| | - P Stagni
- IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
- Child and Adolescent Neuropsychiatry, Department of Mental Health, Modena, Italy
| | - C Street
- Warwick Medical School, University of Warwick, Coventry, UK
| | - P Tah
- Warwick Medical School, University of Warwick, Coventry, UK
| | - E Tanase
- Abteilung für Psychiatrie und Psychotherapie des Kindes-und Jugendalters Weissenau, ZfP Südwürttemberg, Ravensburg, Germany
| | - S Tremmery
- Department of Neurosciences, KU Leuven, Leuven, Belgium
| | - A Tuffrey
- Warwick Medical School, University of Warwick, Coventry, UK
| | - H Tuomainen
- Warwick Medical School, University of Warwick, Coventry, UK
| | - L Walker
- Warwick Medical School, University of Warwick, Coventry, UK
| | - A Wilson
- Warwick Medical School, University of Warwick, Coventry, UK
| | - A Maras
- Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, P.O. Box 2060, 3000 CB, Rotterdam, The Netherlands
- Yulius Academy, Yulius Mental Health Organization, Dordrecht, The Netherlands
| |
Collapse
|
5
|
Gerritsen SE, Maras A, van Bodegom LS, Overbeek MM, Verhulst FC, Wolke D, Appleton R, Bertani A, Cataldo MG, Conti P, Da Fonseca D, Davidović N, Dodig-Ćurković K, Ferrari C, Fiori F, Franić T, Gatherer C, De Girolamo G, Heaney N, Hendrickx G, Kolozsvari A, Levi FM, Lievesley K, Madan J, Martinelli O, Mastroianni M, Maurice V, McNicholas F, O'Hara L, Paul M, Purper-Ouakil D, de Roeck V, Russet F, Saam MC, Sagar-Ouriaghli I, Santosh PJ, Sartor A, Schandrin A, Schulze UME, Signorini G, Singh SP, Singh J, Street C, Tah P, Tanase E, Tremmery S, Tuffrey A, Tuomainen H, van Amelsvoort TAMJ, Wilson A, Walker L, Dieleman GC. Cohort profile: demographic and clinical characteristics of the MILESTONE longitudinal cohort of young people approaching the upper age limit of their child mental health care service in Europe. BMJ Open 2021; 11:e053373. [PMID: 34916319 PMCID: PMC8679118 DOI: 10.1136/bmjopen-2021-053373] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Abstract
PURPOSE The presence of distinct child and adolescent mental health services (CAMHS) and adult mental health services (AMHS) impacts continuity of mental health treatment for young people. However, we do not know the extent of discontinuity of care in Europe nor the effects of discontinuity on the mental health of young people. Current research is limited, as the majority of existing studies are retrospective, based on small samples or used non-standardised information from medical records. The MILESTONE prospective cohort study aims to examine associations between service use, mental health and other outcomes over 24 months, using information from self, parent and clinician reports. PARTICIPANTS Seven hundred sixty-three young people from 39 CAMHS in 8 European countries, their parents and CAMHS clinicians who completed interviews and online questionnaires and were followed up for 2 years after reaching the upper age limit of the CAMHS they receive treatment at. FINDINGS TO DATE This cohort profile describes the baseline characteristics of the MILESTONE cohort. The mental health of young people reaching the upper age limit of their CAMHS varied greatly in type and severity: 32.8% of young people reported clinical levels of self-reported problems and 18.6% were rated to be 'markedly ill', 'severely ill' or 'among the most extremely ill' by their clinician. Fifty-seven per cent of young people reported psychotropic medication use in the previous half year. FUTURE PLANS Analysis of longitudinal data from the MILESTONE cohort will be used to assess relationships between the demographic and clinical characteristics of young people reaching the upper age limit of their CAMHS and the type of care the young person uses over the next 2 years, such as whether the young person transitions to AMHS. At 2 years follow-up, the mental health outcomes of young people following different care pathways will be compared. TRIAL REGISTRATION NUMBER NCT03013595.
Collapse
Affiliation(s)
- Suzanne E Gerritsen
- Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Athanasios Maras
- Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, Rotterdam, The Netherlands
- Yulius Academy, Yulius Mental Health Organization, Dordrecht, The Netherlands
| | - Larissa S van Bodegom
- Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, Rotterdam, The Netherlands
- Yulius Academy, Yulius Mental Health Organization, Dordrecht, The Netherlands
| | - Mathilde M Overbeek
- Yulius Academy, Yulius Mental Health Organization, Dordrecht, The Netherlands
- Clinical Child and Family Studies, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Frank C Verhulst
- Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, Rotterdam, The Netherlands
- Department of Clinical Medicine, University of Copenhagen, Kobenhavn, Denmark
| | - Dieter Wolke
- Department of Psychology, University of Warwick, Warwick, UK
| | - Rebecca Appleton
- Division of Psychiatry, NIHR Mental Health Policy Research Unit, University College London, London, UK
- Warwick Medical School, University of Warwick, Coventry, UK
| | | | - Maria G Cataldo
- IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
- Child and Adolescent Neuropsychiatry Unit, ASST di Lecco, Lecco, Italy
| | | | - David Da Fonseca
- Centre Hospitalier Universitaire de Marseille, Marseille, France
| | - Nikolina Davidović
- University Hospital Center Split, Split, Croatia
- School of Medicine, University of Split, Split, Croatia
| | - Katarina Dodig-Ćurković
- Faculty for Dental Care and Health, Osijek, Croatia
- University Health Center Osijek, Osijek, Croatia
- Unit for Child and Adolescent Psychiatry, Osijek, Croatia
| | - Cecilia Ferrari
- Teenagers' Outpatient Unit, Child and Adolescent Mental Health Services, Niguarda Metropolitan Great Hospital, Milan, Italy
| | - Federico Fiori
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- Centre for Interventional Paediatric Psychopharmacology and Rare Diseases, South London and Maudsley NHS Foundation Trust, London, UK
- HealthTracker Ltd, Kent, UK
| | - Tomislav Franić
- University Hospital Center Split, Split, Croatia
- School of Medicine, University of Split, Split, Croatia
| | | | | | - Natalie Heaney
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Gaëlle Hendrickx
- Department of Neurosciences, Centre for Clinical Psychiatry, KU Leuven, Leuven, Belgium
| | | | - Flavia Micol Levi
- IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
- Psychiatric Unit, ASST Santi Paolo e Carlo, Milano, Italy
| | - Kate Lievesley
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Jason Madan
- Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK
| | | | - Mathilde Mastroianni
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- Centre for Interventional Paediatric Psychopharmacology and Rare Diseases, South London and Maudsley NHS Foundation Trust, London, UK
| | - Virginie Maurice
- Centre Hospitalier Universitaire de Montpellier, Saint Eloi Hospital, Montpellier, France
| | - Fiona McNicholas
- School of Medicine & Medical Science, University College Dublin, Dublin, Ireland
- Lucena CAMHS, SJOG, Dublin, Ireland
| | - Lesley O'Hara
- Saint John of God Research Foundation, Dublin, Ireland
| | - Moli Paul
- Warwick Medical School, University of Warwick, Coventry, UK
- Coventry and Warwickshire Partnership NHS Trust, Coventry, UK
| | - Diane Purper-Ouakil
- Centre Hospitalier Universitaire de Montpellier, Saint Eloi Hospital, Montpellier, France
| | - Veronique de Roeck
- Department of Neurosciences, Centre for Clinical Psychiatry, KU Leuven, Leuven, Belgium
- Child and Youth Studies, Campus Social School, University College Leuven-Limburg, Heverlee, Belgium
| | - Frédérick Russet
- Centre Hospitalier Universitaire de Montpellier, Saint Eloi Hospital, Montpellier, France
| | - Melanie C Saam
- Department of Child and Adolescent Psychiatry/Psychotherapy, University of Ulm, Ulm, Germany
| | - Ilyas Sagar-Ouriaghli
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Paramala J Santosh
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- Centre for Interventional Paediatric Psychopharmacology and Rare Diseases, South London and Maudsley NHS Foundation Trust, London, UK
| | - Anne Sartor
- Josefinum Augsburg, Klinik für Kinder- und Jugenspsychiatrie und Psychotherapie, Augsburg, Germany
| | - Aurélie Schandrin
- Centre Hospitalier Universitaire de Montpellier, Saint Eloi Hospital, Montpellier, France
- Department of Adult Psychiatry, Nimes University Hospital, University of Montpellier, Nimes, France
| | - Ulrike M E Schulze
- Department of Child and Adolescent Psychiatry/Psychotherapy, University of Ulm, Ulm, Germany
| | - Giulia Signorini
- IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Swaran P Singh
- Warwick Medical School, University of Warwick, Coventry, UK
| | - Jatinder Singh
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- Centre for Interventional Paediatric Psychopharmacology and Rare Diseases, South London and Maudsley NHS Foundation Trust, London, UK
| | - Cathy Street
- Warwick Medical School, University of Warwick, Coventry, UK
| | - Priya Tah
- Warwick Medical School, University of Warwick, Coventry, UK
| | - Elena Tanase
- Abteilung für Psychiatrie und Psychotherapie des Kindes-und Jugendalters Weissenau, ZfP Südwürttemberg, Ravensburg, Germany
| | - Sabine Tremmery
- Department of Neurosciences, Centre for Clinical Psychiatry, KU Leuven, Leuven, Belgium
| | - Amanda Tuffrey
- Warwick Medical School, University of Warwick, Coventry, UK
| | | | - Therese A M J van Amelsvoort
- Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands
- Mondriaan Mental Healthcare Group, Heerlen, The Netherlands
| | - Anna Wilson
- Warwick Medical School, University of Warwick, Coventry, UK
| | - Leanne Walker
- Warwick Medical School, University of Warwick, Coventry, UK
| | - Gwen C Dieleman
- Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, Rotterdam, The Netherlands
| |
Collapse
|
6
|
Samama M, Mattos LD, Piscopo RCP, Pereira MAH, Guimaraes CTS, Aranha A, Sale JFDS, Sartor A, Francisco LS, Ikeda F, Ueno J, Bella ZJD. P–679 Magnetic resonance imaging (MRI), an alternative method to evaluate the ovarian reserve. Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Study question
Is magnetic resonance imaging (MRI) a valid method to access antral follicles count (AFC) compared to two-dimensional (2D) transvaginal ultrasonography (USG) and Anti-Mullerian Hormone (AMH) to evaluate the ovarian reserve?
Summary answer
AFC has a high agreement between MRI and USG methods, as well as with AMH. MRI can be an alternative method to evaluate ovarian reserve.
What is known already
In fact, two methods are the most used today to assess ovarian reserve: USG and AMH. The USG is considered the gold standard method for AFC, and contributes to predict and tailor treatment strategies, such as in-vitro fertilization. The major limitations of USG are its user dependency and equipment. Also, there are limitations in displaying a global view of the pelvis and large ovarian lesions. Magnetic resonance imaging (MRI), with its excellent soft-tissue contrast resolution and characteristics, is a useful non-invasive alternative modality to USG. Just one study evaluated MRI and revealed more small size antral follicles compared to 3D-USG.
Study design, size, duration
A prospective cross-sectional observational study was performed in an assisted reproduction techniques (ART) post-graduation program setting from an assisted reproductive center in Sao Paulo, Brazil, which ran throughout 2019–2020, with a total number of 59 patients that were in fertility treatment and needed to undergo to a MRI procedure to evaluate uterine or pelvic diseases as, Myoma, Adenomyosis, endometriosis, and adnexal cysts.
Participants/materials, setting, methods
Patients were evaluated to access the AFC by the MRI method and 2D transvaginal USG, and Anti-Mullerian Hormone (AMH) concentration to evaluate the ovarian reserve. Comparison between methods was done through Wilcoxon signed ranks test and Bland-Altman analysis. Ovarian reserve was classified as follows: very low (<4 follicles/AMH<0.5); low (5–7 follicles/AMH=0.5–1.1); normal (8–15 follicles/AMH=1.1–3.5); normal-high (>15 follicles/AMH>3.5). Weighted Cohen’s kappa was used to verify agreement between MRI, USG and AMH classifications of ovarian reserve.
Main results and the role of chance
Average AFC for USG were 5,55±4.01 for left ovary and 5.55±3.8 for right ovary. Average follicle count for both ovaries was 10±7.07. Regarding MRI, mean counts were 6.44±4.81 for left ovary, 5.65±3.85 for right ovary, and a 11.89±7.89 follicle sum mean count. Average concentration of AMH was 1.79±1.44. The Wilcoxon test and Bland-Altman analyses found differences and systematic biases for comparison between USG and MRI for both ovaries (–2.58; limits of agreement=–14.56 to 9.40, Wilcoxon p = 0,008) and for the right ovary (–1.48; limits of agreement=–8.32 to 5.35, Wilcoxon p = 0,031). There was no difference between methods for the left ovary. Weighted Cohen Kappa coefficients showed substantial agreement between ovarian reserve classifications based on AMH levels, USG, and MRI. The conducted paired comparisons were USG with MRI (k = 0.676), AMH with MRI (k = 0.760) and USG (k = 0.609).
Limitations, reasons for caution
The systematic biases found when comparing USG to MRI methods may suggest a consistent detection of more follicles with MRI procedures in comparison to the USG method. This bias found warrants caution as it must be confirmed, in future studies.
Wider implications of the findings: The MRI method reveals similar ovarian reserve to USG when used the same classification, and a higher agreement to AMH. This suggests that MRI is a reliable method of quantifying antral follicles and can also be adopted when the patient will need to evaluate pelvic pathologies.
Trial registration number
Not applicable
Collapse
Affiliation(s)
- M Samama
- Escola Paulista de Medicina/ Universidade Federal de São Paulo, Department of Gynecology, Sao Paulo / SP, Brazil
- GERA Institute-São Paulo-Brazil, Post-graduation, São Paulo, Brazil
| | - L.A. D Mattos
- Laboratório DASA/ALTA excelência diagnóstica., Magnetic resonance imaging, São Paulo, Brazil
| | - R C P Piscopo
- GERA Institute-São Paulo-Brazil, Post-graduation, São Paulo, Brazil
| | - M A H Pereira
- Laboratório DASA/ALTA excelência diagnóstica., Magnetic resonance imaging, São Paulo, Brazil
| | - C T S Guimaraes
- Laboratório DASA/ALTA excelência diagnóstica., Magnetic resonance imaging, São Paulo, Brazil
| | - A Aranha
- Laboratório DASA/ALTA excelência diagnóstica., Magnetic resonance imaging, São Paulo, Brazil
| | - J F D S Sale
- GERA Institute-São Paulo-Brazil, Post-graduation, São Paulo, Brazil
| | - A Sartor
- GERA Institute-São Paulo-Brazil, Post-graduation, São Paulo, Brazil
| | - L S Francisco
- GERA Institute-São Paulo-Brazil, Post-graduation, São Paulo, Brazil
| | - F Ikeda
- GERA Institute-São Paulo-Brazil, Post-graduation, São Paulo, Brazil
| | - J Ueno
- GERA Institute-São Paulo-Brazil, Post-graduation, São Paulo, Brazil
| | - Z. Jarmy-D Bella
- Escola Paulista de Medicina/ Universidade Federal de São Paulo, Department of Gynecology, Sao Paulo / SP, Brazil
| |
Collapse
|
7
|
Valent F, Gallo T, Mazzolini E, Pipan C, Sartor A, Merelli M, Bontempo G, Marzinotto S, Curcio F, Tascini C. A cluster of COVID-19 cases in a small Italian town: a successful example of contact tracing and swab collection. Clin Microbiol Infect 2020; 26:1112-1114. [PMID: 32344169 PMCID: PMC7194962 DOI: 10.1016/j.cmi.2020.04.028] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2020] [Revised: 04/16/2020] [Accepted: 04/21/2020] [Indexed: 11/17/2022]
Affiliation(s)
- F Valent
- SOC Istituto di Igiene ed Epidemiologia Clinica, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
| | - T Gallo
- Dipartimento di Prevenzione, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
| | - E Mazzolini
- Direzione Centrale Salute, Politiche Sociali e Disabilità, Regione Autonoma Friuli Venezia Giulia, Udine, Italy
| | - C Pipan
- SOC Istituto di Igiene ed Epidemiologia Clinica, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
| | - A Sartor
- SOC Microbiologia, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
| | - M Merelli
- Clinica di Malattie Infettive, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
| | - G Bontempo
- Clinica di Malattie Infettive, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
| | - S Marzinotto
- Dipartimento di Medicina di Laboratorio, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
| | - F Curcio
- Dipartimento di Medicina di Laboratorio, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
| | - C Tascini
- Clinica di Malattie Infettive, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
| |
Collapse
|
8
|
Prigitano A, Esposto MC, Grancini A, Passera M, Paolucci M, Stanzani M, Sartor A, Candoni A, Pitzurra L, Innocenti P, Micozzi A, Cascio GL, Delia M, Mosca A, Mikulska M, Ossi C, Fontana C, Pizzolante M, Gelmi M, Cavanna C, Lallitto F, Amato G, Vella A, Pagano L, Bandettini R, De Lorenzis G, Cogliati M, Romanò L, Tortorano A. Prospective multicentre study on azole resistance in Aspergillus isolates from surveillance cultures in haematological patients in Italy. J Glob Antimicrob Resist 2020; 22:231-237. [PMID: 32061880 DOI: 10.1016/j.jgar.2020.01.016] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2019] [Revised: 01/16/2020] [Accepted: 01/25/2020] [Indexed: 10/25/2022] Open
Abstract
OBJECTIVES This study was conducted to assess the prevalence of azole resistance in Aspergillus isolates from patients with haematological malignancies or who were undergoing haematopoietic stem cell transplantation and to identify the molecular mechanism of resistance. METHODS In this 28-month prospective study involving 18 Italian centres, Aspergillus isolates from surveillance cultures were collected and screened for azole resistance, and mutations in the cyp51A gene were identified. Resistant isolates were genotyped by microsatellite analysis, and the allelic profiles were compared with those of resistant environmental and clinical isolates from the same geographical area that had been previously genotyped. RESULTS There were 292 Aspergillus isolates collected from 228 patients. The isolates belonged mainly to the section Fumigati (45.9%), Nigri (20.9%), Flavi (16.8%) and Terrei (4.8%). Three isolates showed itraconazole resistance: Aspergillus fumigatus sensu stricto, Aspergillus lentulus (section Fumigati) and Aspergillus awamori (section Nigri). The itraconazole resistance rates were 1% and 1.48% considering all Aspergillus spp. isolates and the Aspergillus section Fumigati, respectively. The prevalence of azole resistance among all the patients was 1.3%. Among patients harbouring A. fumigatus sensu stricto isolates, the resistance rate was 0.79%. The A. fumigatus isolate, with the TR34/L98H mutation, was genotypically distant from the environmental and clinical strains previously genotyped. CONCLUSIONS In this study, the Aspergillus azole resistance rate was 1% (3/292). In addition to A. fumigatus sensu stricto, A. lentulus and A. awamori azole-resistant isolates were identified. Therefore, it is important have a correct identification at the species level to address a rapid therapy better, quickly understand the shift towards cryptic species and have an updated knowledge of the local epidemiology.
Collapse
Affiliation(s)
- A Prigitano
- Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy.
| | - M C Esposto
- Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy
| | - A Grancini
- I.R.C.C.S. Foundation, Cà Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - M Passera
- Microbiology and Virology Unit, Asst. Papa Giovanni XXIII, Bergamo, Italy
| | - M Paolucci
- Institute of Hematology, Lorenzo e Ariosto Seràgnoli, Sant'Orsola-Malpighi Hospital Policlinico, University of Bologna, Bologna, Italy
| | - M Stanzani
- Institute of Hematology, Lorenzo e Ariosto Seràgnoli, Sant'Orsola-Malpighi Hospital Policlinico, University of Bologna, Bologna, Italy
| | - A Sartor
- Division of Hematology, ASUIUD, University of Udine, Udine, Italy
| | - A Candoni
- Division of Hematology, ASUIUD, University of Udine, Udine, Italy
| | - L Pitzurra
- Dipartimento di Medicina, Università degli Studi di Perugia, Perugia, Italy
| | - P Innocenti
- Laboratory of Microbiology and Virology, Comprensorio Sanitario di Bolzano-AS Alto Adige, Bolzano, Italy
| | - A Micozzi
- Department of Translational and Precision Medicine, Sapienza Università di Roma, Rome, Italy
| | - G Lo Cascio
- Microbiology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
| | - M Delia
- Department of Emergency and Organ Transplantation-UO Haematology with transplantation, AO Universitaria Policlinico di Bari, Bari, Italy
| | - A Mosca
- Interdisciplinary Department of Medicine, AO Universitaria Policlinico di Bari, Bari, Italy
| | - M Mikulska
- Università degli Studi di Genova (DISSAL) and Ospedale Policlinico San Martino, Genoa, Italy
| | - C Ossi
- Laboratory of Microbiology and Virology, San Raffaele Scientific Institute, Milan, Italy
| | - C Fontana
- Department of Experimental Medicine, University of Tor Vergata Polyclinic of Tor Vergata, Rome, Italy
| | - M Pizzolante
- Laboratory of Microbiology, Vito Fazzi Regional Hospital Lecce, Lecce, Italy
| | - M Gelmi
- ASST Spedali Civili di Brescia, Brescia, Italy
| | - C Cavanna
- Microbiology and Virology Unit, IRCCS Policlinico San Matteo, Pavia, Italy
| | - F Lallitto
- Microbiology and Virology Unit, IRCCS Policlinico San Matteo, Pavia, Italy
| | - G Amato
- UOC. Patologia Clinica, AO A. Cardarelli, Naples, Italy
| | - A Vella
- Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
| | - L Pagano
- Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy
| | - R Bandettini
- Clinical Pathology and Microbiology Laboratory Unit, Istituto Giannina Gaslini, Genoa, Italy
| | - G De Lorenzis
- Department of Agricultural and Environmental Sciences-Production, Landscape, Agroenergy, Università degli Studi di Milano, Milan, Italy
| | - M Cogliati
- Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy
| | - L Romanò
- Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy
| | - A Tortorano
- Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy
| |
Collapse
|
9
|
Delacourt C, Bertille N, Salomon LJ, Benachi A, Henry E, Massardier J, Mottet N, Rosenblatt J, Sartor A, Thong-Vanh C, Valat-Rigot AS, Winer N, Lelong N, Khoshnood B. Prenatal natural history of congenital pulmonary malformations: MALFPULM population-based cohort study. Ultrasound Obstet Gynecol 2019; 54:381-388. [PMID: 30264541 DOI: 10.1002/uog.20130] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2018] [Revised: 09/10/2018] [Accepted: 09/18/2018] [Indexed: 06/08/2023]
Abstract
OBJECTIVES To assess prenatal changes in the volume of congenital pulmonary malformations (CPM) and examine whether these changes differ in lesions that appear cystic on ultrasound compared with hyperechoic lesions, and to study the relationship between CPM volume and risk of fetal compression. METHODS We conducted a nationally representative, multicenter, prospective cohort study, which included 579 ultrasound examinations in 176 pregnant women with a diagnosis of fetal CPM, between March 2015 and November 2016. Several ultrasound examinations were performed between diagnosis and delivery, including measurement of CPM volume. We modeled changes in CPM volume ratio (CVR) as a function of gestational age, overall and for cystic/mixed vs hyperechoic malformations, and examined the association between CVR and signs of compression during pregnancy. RESULTS When modeling CVR changes over time, there was a statistically significant decrease in CVR with increasing gestational age (P < 0.001), but the pattern of change differed according to CPM phenotype at first ultrasound examination: cystic/mixed CPM were characterized by a monotonic decrease in CVR with increasing gestational age (P = 0.002), whereas hyperechoic CPM showed an initial increase in CVR up to 27 weeks of gestation, followed by a decrease thereafter (P < 0.001). Peak CVR values were predicted as early as 21-22 weeks for cystic/mixed CPMs compared with 25-26 weeks for hyperechoic malformations. Regardless of CPM phenotype, fetuses that showed no sign of compression at any point had substantially lower CVR at first CVR measurement, and the CVR remained relatively constant thereafter. Among the subpopulation of fetuses with no sign of compression at first CVR measurement, the odds of a subsequent compression was 7-fold higher (adjusted odds ratio, 7.0; 95% CI, 1.6-29.9) if initial CVR was > 0.4 vs CVR ≤ 0.4 cm2 . CONCLUSIONS Predicted changes in CVR during pregnancy differ between cystic and hyperechoic malformations. This may be the result of different pathophysiological mechanisms or differences in the timing of occurrence of these different types of CPM. CVR measured at the initial diagnostic ultrasound examination was strongly associated with the odds of subsequent compression. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.
Collapse
Affiliation(s)
- C Delacourt
- AP-HP, Hôpital Necker-Enfants Malades, Service de Pneumologie et Allergologie Pédiatriques, Paris, France
- Université Paris Descartes-Sorbonne Paris Cité, Paris, France
| | - N Bertille
- Inserm UMR 1153, Maternité Port-Royal, Paris, France
| | - L J Salomon
- Université Paris Descartes-Sorbonne Paris Cité, Paris, France
- AP-HP, Hôpital Necker-Enfants Malades, Service d'Obstétrique, Paris, France
| | - A Benachi
- AP-HP, Hôpital Antoine Béclère, Service de Gynécologie-Obstétrique, Université Paris Sud, Clamart, France
| | - E Henry
- AP-HP, Unité de Recherche Clinique Cochin-Necker, Paris, France
| | - J Massardier
- Hospices Civils de Lyon, HFME, Service d'Obstétrique, Lyon, France
| | - N Mottet
- Service d'Obstétrique, CHU Besançon, Besançon, France
| | - J Rosenblatt
- AP-HP, Hôpital Robert Debré, Service d'Obstétrique, Paris, France
| | - A Sartor
- Service d'Obstétrique, CHU Toulouse, Toulouse, France
| | - C Thong-Vanh
- Service d'Obstétrique, CHU Grenoble, Grenoble, France
| | | | - N Winer
- Service Gynécologie Obstétrique Université Nantes, UMR PhAN 1280 Physiologie des Adaptations Nutritionnelles INRA, Nantes, France
| | - N Lelong
- Inserm UMR 1153, Maternité Port-Royal, Paris, France
| | - B Khoshnood
- Inserm UMR 1153, Maternité Port-Royal, Paris, France
| |
Collapse
|
10
|
Righi E, La Rosa A, Sartor A, Londero A, Carnelutti A, Bassetti M. Persistent hematogenous dissemination in pulmonary P. jiroveci infection. Mycopathologia 2019; 184:457-458. [PMID: 30955129 DOI: 10.1007/s11046-019-00332-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2019] [Accepted: 03/19/2019] [Indexed: 11/24/2022]
Abstract
Pneumocystis jiroveci pneumonia in non-HIV patients is infrequent and characterized by atypical presentations and increased severity. Although hematogenous dissemination from the lungs can lead to extrapulmonary infections, isolation of oocysts from blood in human subjects has not been documented. We report a case of P. jiroveci pneumonia with persistent isolation of oocysts from blood and positivity of P. jiroveci polymerase chain reaction. The patient presented with bilateral diffuse pulmonary nodules and received prolonged treatment with trimethoprim/sulfamethoxazole.
Collapse
Affiliation(s)
- E Righi
- Infectious Diseases Division, Santa Maria della Misericordia University Hospital, Udine, Italy. .,Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
| | - A La Rosa
- Infectious Diseases Division, Santa Maria della Misericordia University Hospital, Udine, Italy
| | - A Sartor
- Microbiology Division, Santa Maria della Misericordia University Hospital, Udine, Italy
| | - A Londero
- Infectious Diseases Division, Santa Maria della Misericordia University Hospital, Udine, Italy
| | - A Carnelutti
- Infectious Diseases Division, Santa Maria della Misericordia University Hospital, Udine, Italy
| | - M Bassetti
- Infectious Diseases Division, Santa Maria della Misericordia University Hospital, Udine, Italy
| |
Collapse
|
11
|
Senat MV, Bouchghoul H, Stirnemann J, Vaast P, Boubnova J, Begue L, Carricaburu E, Sartor A, Jani J, Benachi A, Bouyer J. Prognosis of isolated congenital diaphragmatic hernia using lung-area-to-head-circumference ratio: variability across centers in a national perinatal network. Ultrasound Obstet Gynecol 2018; 51:208-213. [PMID: 28295742 DOI: 10.1002/uog.17463] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/15/2016] [Revised: 02/20/2017] [Accepted: 03/03/2017] [Indexed: 06/06/2023]
Abstract
OBJECTIVE Congenital diaphragmatic hernia (CDH) is a severe anomaly. The observed-to-expected lung-area-to-head-circumference ratio (o/e-LHR) has been shown to provide a useful prediction of subsequent survival of fetuses with CDH in referral centers with expertise and a large caseload. However, the accuracy of o/e-LHR measurements in general fetal medicine units with less expertise is not well known. The aim of this study was to evaluate the capacity of o/e-LHR to provide a useful prediction of mortality of fetuses with CDH when the measurement is performed in fetal medicine units with different levels of expertise. METHODS Between January 2008 and November 2013, 305 live births with expectantly managed left-sided isolated CDH were recorded in the database of the French National Center for Rare Diseases (31 centers) and followed up after birth. Centers were grouped into two categories according to their mean annual CDH caseload over the study period: large centers with an average of ≥ 14 cases and smaller centers with < 14 cases per year. The relationship between o/e-LHR and 28-day and 6-month mortality was modeled using fractional polynomials and the predictive value of o/e-LHR was quantified using the area under the receiver-operating characteristics curve. Comparisons between the two center categories were carried out. Analyses were adjusted for potential confounders such as thoracic herniation of the liver and gestational age at birth and at diagnosis. RESULTS During the study period, two large centers managed a total of 82 CDH cases and 29 smaller centers a total of 223 CDH cases. Overall, there was a significant inverse relationship between 28-day mortality rate and o/e-LHR, which decreased from 54% when o/e-LHR was 20% to 6% when o/e-LHR was 75% (P < 0.01). When the category of center was considered, adjusted associations between o/e-LHR and 28-day mortality were significantly different (P = 0.032) between large and smaller centers. The ability to predict survival at 28 days postpartum based on o/e-LHR was better in large centers; for a specificity of 0.30, the sensitivity was 0.71 in large centers and 0.55 in smaller ones. The results were similar for 6-month mortality. CONCLUSIONS Our results show that o/e-LHR measured on two-dimensional ultrasound is a good indicator of neonatal prognosis in cases of CDH that may be used even in fetal medicine centers with a small caseload. However, our results also suggest that LHR measurement may be difficult to perform correctly. Therefore, appropriate training should be offered to professionals. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
Collapse
Affiliation(s)
- M-V Senat
- Center for Research in Epidemiology and Population Health (CESP), Université Paris-Saclay, Université Paris-Sud, UVSQ, INSERM, Villejuif, France
- Centre Maladie Rare: Hernie de Coupole Diaphragmatique, Paris, France
- Department of Obstetrics and Gynecology, Hôpital Bicêtre, AP-HP, Université Paris-Sud, Le Kremlin-Bicêtre, France
| | - H Bouchghoul
- Center for Research in Epidemiology and Population Health (CESP), Université Paris-Saclay, Université Paris-Sud, UVSQ, INSERM, Villejuif, France
- Centre Maladie Rare: Hernie de Coupole Diaphragmatique, Paris, France
- Department of Obstetrics and Gynecology, Hôpital Bicêtre, AP-HP, Université Paris-Sud, Le Kremlin-Bicêtre, France
| | - J Stirnemann
- Department of Obstetrics and Maternal-Fetal Medicine, Necker-Enfants Malades Hospital, AP-HP, Paris, France
- Université Paris Descartes 5 CHU Lille, Pôle Femme Mère Nouveau-né, Lille, France
| | - P Vaast
- Centre Maladie Rare: Hernie de Coupole Diaphragmatique, Paris, France
- Université Lille, EA 4489, Environnement Périnatal et Santé, Lille, France
| | - J Boubnova
- Centre Maladie Rare: Hernie de Coupole Diaphragmatique, Paris, France
- Service de Chirurgie Pédiatrique, Hôpital de la Timone, Marseille, France
| | - L Begue
- Service de Gynécologie-Obstétrique, Centre Hospitalier Universitaire, Montpellier, France
| | - E Carricaburu
- Service de Chirurgie Pédiatrique, Hopital Robert Debré, AP-HP, Paris, France
| | - A Sartor
- Service de Gynécologie-Obstétrique Paule de Viguier Hospital, Toulouse, France
| | - J Jani
- Department of Obstetrics and Gynecology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium
| | - A Benachi
- Centre Maladie Rare: Hernie de Coupole Diaphragmatique, Paris, France
- Service de Gynécologie-Obstétrique, Hôpital Antoine Béclère, AP-HP, Paris-Sud, Paris-Saclay University, Clamart, France
| | - J Bouyer
- Center for Research in Epidemiology and Population Health (CESP), Université Paris-Saclay, Université Paris-Sud, UVSQ, INSERM, Villejuif, France
| |
Collapse
|
12
|
Rochester C, Sartor A, Pruessner G, Kornyshev AA. “One dimensional” double layer. The effect of size asymmetry of cations and anions on charge-storage in ultranarrow nanopores—an Ising model theory. RUSS J ELECTROCHEM+ 2017. [DOI: 10.1134/s102319351710010x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
13
|
Paganelli G, Rossetti C, Aglietta M, Messina C, Versari A, Michalski J, O'Sullivan J, Parker C, Garcia-Vargas J, Sartor A, Finkelstein S. External beam radiation therapy (EBRT) use and safety with radium-223 dichloride (Ra-223) in patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets) from the ALSYMPCA trial. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv341.31] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
14
|
Amadori D, Rossetti C, Aglietta M, Messina C, Versari A, Vogelzang N, Sartor A, Coleman R, Govi S, Fang F, Skjorestad I, Nilsson S, Parker C. 3-year safety follow-up of radium-223 dichloride (Ra-223) in patients (Pts) with castration resistant prostate cancer (CRPC) and symptomatic bone metastases (Mets) from ALSYMPCA. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv341.07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
15
|
Ejadi S, Vogelzang N, Sartor A, Clark R, Tolcher A. 362 Phase 1 study of the PSMA-targeted tubulysin small-molecule drug conjugate EC1169 in patients with metastatic castrate-resistant prostate cancer (mCRPC). Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)30225-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
16
|
Zéphir P, Decramer S, Sartor A, Vayssière C. [Lowe syndrome revealed by prenatal diagnosis of congenital cataract with brain abnormalities]. ACTA ACUST UNITED AC 2013; 42:350-2. [PMID: 24309025 DOI: 10.1016/j.gyobfe.2013.06.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2012] [Accepted: 05/29/2013] [Indexed: 10/26/2022]
Abstract
Congenital cataract is a rare disease whose incidence is estimated to 0.5% of birth in France. A study of the literature shows that congenital cataract is idiopathic in 50% of cases, hereditary forms representing 25% of cases. Other causes of congenital cataract are represented by viral embryofoetopathies acquired during pregnancy, metabolic disorders and chromosomal aberrations within the scope of malformative syndromes. The authors report the case of a neonatal diagnosis of Lowe syndrome suspected by the discovery of bilateral cataract initially isolated. The morphological exploration was completed by secondary brain abnormalities (periventricular lesions). The etiological prenatal exploration was negative. Lowe syndrome is a rare cause of antenatal cataract, which so far only one case has been reported.
Collapse
Affiliation(s)
- P Zéphir
- Service d'échographie et de diagnostic anténatal, hôpital Paule-de-Viguier, 330, avenue de Grande-Bretagne, TSA 70034, 31059 Toulouse cedex 9, France.
| | - S Decramer
- Service de néphrologie pédiatrique médecine interne et HTA, hôpital des Enfants, 330, avenue de Grande-Bretagne, TSA 70034, 31059 Toulouse cedex 9, France
| | - A Sartor
- Service d'échographie et de diagnostic anténatal, hôpital Paule-de-Viguier, 330, avenue de Grande-Bretagne, TSA 70034, 31059 Toulouse cedex 9, France
| | - C Vayssière
- Service d'échographie et de diagnostic anténatal, hôpital Paule-de-Viguier, 330, avenue de Grande-Bretagne, TSA 70034, 31059 Toulouse cedex 9, France
| |
Collapse
|
17
|
Bassetti M, Pecori D, Sartor A, Londero A, Villa G, Cadeo B, Brillo F, Bongiorno D, Campanile F, Stefani S. First report of endocarditis by Gluconobacter spp. in a patient with a history of intravenous-drug abuse. J Infect 2013; 66:285-7. [DOI: 10.1016/j.jinf.2012.05.006] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2012] [Revised: 05/10/2012] [Accepted: 05/17/2012] [Indexed: 12/01/2022]
|
18
|
Fazal Janot J, Cougoul P, Comont T, Sartor A, Bloom D, Ollier S, Beyne-Rauzy O, Parant O, Adoue D. Drépanocytose et grossesse : l’expérience du CHU de Toulouse. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.03.341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
19
|
Groussolles M, Sartor A, Connan L, Vayssière C. Evolution of middle cerebral artery peak systolic velocity after a successful laser procedure for iatrogenic twin anemia-polycythemia sequence. Ultrasound Obstet Gynecol 2012; 39:354-356. [PMID: 21425195 DOI: 10.1002/uog.8999] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 03/10/2011] [Indexed: 05/30/2023]
Abstract
We report a case of twin anemia-polycythemia sequence (TAPS) treated by laser at 24 + 5 weeks' gestation, 7 weeks after a first laser procedure for twin-to-twin transfusion syndrome at 16 + 6 weeks. This management led to the birth of two healthy neonates by Cesarean section at 36 weeks. In this case, weekly measurement of the middle cerebral artery peak systolic velocity allowed us to monitor the twins after both laser treatments and, more specifically, to detect TAPS. Following delivery, placental injection showed a minuscule coagulated arteriovenous anastomosis. Intrauterine transfusion is generally chosen to manage TAPS, but the choice of therapy must consider gestational age, technical difficulties and disease severity. The laser procedure cannot be used as a curative treatment for TAPS in all cases. We propose a decisional algorithm to help clinicians select the appropriate treatment.
Collapse
Affiliation(s)
- M Groussolles
- Division of Prenatal Diagnosis, Department of Obstetrics and Gynecology, Hôpital Paule de Viguier, Toulouse, France.
| | | | | | | |
Collapse
|
20
|
Ballouhey Q, Sartor A, Baunin C, Danjoux M, Léobon B, Galinier P, Vayssiere C. [Unusual fetal teratoma presenting as a posterior mediastinal cyst]. ACTA ACUST UNITED AC 2012; 41:338-40. [PMID: 22296937 DOI: 10.1016/j.gyobfe.2011.07.048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2011] [Accepted: 07/11/2011] [Indexed: 10/14/2022]
Abstract
Mediastinal cysts are uncommon prenatal findings. As isolated and non-compressing entities, they don't compromise the course of gestation. Massive lesions can compress vital structures, resulting in fetal demise. Thus, close follow-up with sonographic monitoring is recommended until birth. Non-hydroptic fetuses can be managed expectantly. Definitive etiology is known after surgical resection only. We present the first case of posterior mediastinal teratoma associated with severe vertebral abnormalities. After CT scan and fetal MRI, medical termination of pregnancy was decided. Histological examination revealed an immature teratoma. With this unique case report, we discuss the optimal prenatal management of mediastinal cysts.
Collapse
Affiliation(s)
- Q Ballouhey
- Service de chirurgie pédiatrique, hôpital des Enfants, 330 avenue de Grande-Bretagne, Toulouse cedex 9, France.
| | | | | | | | | | | | | |
Collapse
|
21
|
Lanzafame P, Sartor A, Baron M. ATTIVITÀ IN VITRO DI PRULIFLOXACINA VS. P.AERUGINOSA: CONFRONTO CON CIPROFLOXACINA E LEVOFLOXACINA. Microbiol Med 2006. [DOI: 10.4081/mm.2006.3385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
22
|
Baron M, Hitzel A, Sartor A, d'Anjou J, Dessogne P. Maladie de Paget de la vulve : intérêt de l'étude du ganglion sentinelle. ACTA ACUST UNITED AC 2006; 34:619-21. [PMID: 16854611 DOI: 10.1016/j.gyobfe.2006.03.027] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2005] [Accepted: 03/07/2006] [Indexed: 11/29/2022]
Abstract
Paget's disease of the vulva is difficult to diagnose, as far as the extent of this lesion is concerned, since it is often coupled with invasive adenocarcinoma of the vulva. Thus, we present two cases of Paget's disease of the vulva, with use of sentinel lymph node analysis- a non-validated technique in this very context. Evaluation of sentinel lymph node may be useful in case of micro-invasive Paget's disease.
Collapse
Affiliation(s)
- M Baron
- Département de chirurgie gynécologique, centre régional de lutte contre le cancer de Haute-Normandie, centre Henri-Becquerel, 80, rue d'Amiens, 76000 Rouen, France.
| | | | | | | | | |
Collapse
|
23
|
Whitby M, McLaws ML, Collopy B, Looke DFL, Doidge S, Henderson B, Selvey L, Gardner G, Stackelroth J, Sartor A. Post-discharge surveillance: can patients reliably diagnose surgical wound infections? J Hosp Infect 2002; 52:155-60. [PMID: 12419265 DOI: 10.1053/jhin.2002.1275] [Citation(s) in RCA: 82] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Post-discharge surgical wound infection surveillance is an important part of many infection control programs. It is frequently undertaken by patient self-assessment, prompted either by a telephone or postal questionnaire. To assess the reliability of this method, 290 patients were followed for six weeks postoperatively. Their wounds were photographed and also covertly assessed for signs of infection by two experienced infection control nurses (ICNs). Patients also responded to a postal questionnaire seeking evidence of infection at both week four and week six post-surgery. Correlation between the patient's assessment of their wound and the ICNs diagnosis was poor (r = 0.37) with a low positive predictive value (28.7%), although negative predictive value was high (98.2%). Assessment of photos for signs of infection by two experienced clinicians also correlated poorly with the ICNs diagnosis of infection (r = 0.54). The patient's recall of prescription of an antibiotic by their general practitioner (GP) for wound infection during the postoperative period correlated best with the ICNs diagnosis (r = 0.76). This latter measure, particularly when confirmed by the GP in those patients reporting an infection, appears to provide the most valid and resource efficient marker of post-discharge surgical wound infection.
Collapse
Affiliation(s)
- M Whitby
- Infection Management Services, Princess Alexandra Hospital, Brisbane, Australia.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Morton AP, Whitby M, McLaws ML, Dobson A, McElwain S, Looke D, Stackelroth J, Sartor A. The application of statistical process control charts to the detection and monitoring of hospital-acquired infections. J Qual Clin Pract 2001; 21:112-7. [PMID: 11856406 DOI: 10.1046/j.1440-1762.2001.00423.x] [Citation(s) in RCA: 68] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The monitoring of infection control indicators including hospital-acquired infections is an established part of quality maintenance programmes in many health-care facilities. However, surveillance data use can be frustrated by the infrequent nature of many infections. Traditional methods of analysis often provide delayed identification of increasing infection occurrence, placing patients at preventable risk. The application of Shewhart, Cumulative Sum (CUSUM) and Exponentially Weighted Moving Average (EWMA) statistical process control charts to the monitoring of indicator infections allows continuous real-time assessment. The Shewhart chart will detect large changes, while CUSUM and EWMA methods are more suited to recognition of small to moderate sustained change. When used together, Shewhart and EWMA methods are ideal for monitoring bacteraemia and multiresistant organism rates. Shewhart and CUSUM charts are suitable for surgical infection surveillance.
Collapse
Affiliation(s)
- A P Morton
- Infection Management Services, Princess Alexandra Hospital, Ipswich Road, Brisbane, Queensland 4102, Australia.
| | | | | | | | | | | | | | | |
Collapse
|